Previous product
Back to products
Aliqopa (copanlisib)
CHF5,474.93
Next product
Cyramza (ramucirumab)
CHF518.51
Verzenio/Verzenios (abemaciclib)
CHF1,366.68
Verzenio (abemaciclib) is a medication indicated for the treatment of women with HR-positive, HER2-negative advanced or metastatic breast cancer.
Reviews
There are no reviews yet.